Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100

Author： Idaan-Heikkila I.   Wahlstrom E.   Muttilainen S.   Nurminen M.   Kayhty H.   Sarvas M.   Makela P.H.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.14, Iss.9, 1996-06, pp. : 886-891

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis

By Idanpaan-Heikkila I.   Muttilainen S.   Wahlstrom E.   Saarinen L.   Leinonen M.   Sarvas M.   Makela P.H.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1501-1508

Elsevier

Access to resources Recommend Favorite

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins

By Cartwright K.   Morris R.   Rumke H.   Fox A.   Ray Borrow   Begg N.   Richmond P.   Poolman J.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2612-2619

Elsevier

Access to resources Recommend Favorite

Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine

By Martin S.L.   Borrow R.   van der Ley P.   Dawson M.   Fox A.J.   Cartwright K.A.V.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2476-2481

Elsevier

Access to resources Recommend Favorite

Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine

By Claassen I.   Meylis J.   van der Ley P.   Peeters C.   Brons H.   Robert J.   Borsboom D.   van der Ark A.   van Straaten I.   Roholl P.   Kuipers B.   Poolman J.  

Vaccine, Vol. 14, Iss. 10, 1996-07 ,pp. : 1001-1008

Elsevier

Access to resources Recommend Favorite

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile

By Boslego J.   Garcia J.   Cruz C.   Zollinger W.   Brandt B.   Ruiz S.   Martinez M.   Arthur J.   Underwood P.   Silva W.   Moran E.   Hankins W.   Gilly J.   Mays J.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 821-829

Elsevier

Access to resources Recommend Favorite